USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| May 17, 2022 (est) | Mar 31, 2022 | $-0.17 | $-0.28 | $-0.30 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| May 17, 2022 (est) | Mar 31, 2022 | $0.00 | $0.00 | $0.00 |
Adial Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is May 17, 2022 for the fiscal quarter ending Mar 31, 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 1 | $-0.17 | $-0.17 | $-0.17 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 2 | $-0.64 | $-0.67 | $-0.62 |
| Dec 2023 | 2 | $-0.14 | $-0.22 | $-0.06 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 0 / 0 | $-0.17 | $-0.17 | $-0.17 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 1 / 0 | $-0.71 | $-0.71 | $-0.75 |
| Dec 2023 | 0 / 0 | $-0.14 | $-0.14 | $-0.14 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 1 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 2 | $0.00 | $0.00 | $0.00 |
| Dec 2023 | 2 | $11.79M | $0.00 | $23.58M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 28, 2022 | Dec 2021 | $-0.21 | $-0.28 | -33.33% |
| Nov 15, 2021 | Sep 2021 | $-0.22 | $-0.22 | 1.48% |
| Aug 12, 2021 | Jun 2021 | $-0.21 | $-0.25 | -21.95% |
| May 17, 2021 | Mar 2021 | - | $-0.30 | - |
| Mar 22, 2021 | Dec 2020 | $-0.25 | $-0.25 | - |
| Nov 13, 2020 | Sep 2020 | $-0.18 | $-0.24 | -33.33% |
| Aug 13, 2020 | Jun 2020 | $-0.18 | $-0.16 | 11.11% |
| May 14, 2020 | Mar 2020 | - | $-0.22 | - |
| Mar 20, 2020 | Dec 2019 | $-0.19 | $-0.19 | - |
| Nov 14, 2019 | Sep 2019 | $-0.29 | $-0.17 | 41.38% |
| Aug 13, 2019 | Jun 2019 | $-0.23 | $-0.21 | 8.70% |
| May 13, 2019 | Mar 2019 | $-0.17 | $-0.33 | -94.12% |
| Feb 19, 2019 | Dec 2018 | $-0.18 | $-0.19 | -5.56% |
| Nov 14, 2018 | Sep 2018 | $-0.26 | $-1.48 | -469.23% |
| Jul 30, 2018 | Jun 2018 | - | $-0.27 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 28, 2022 | Dec 2021 | $-0.96 | $-1.05 | - |
| Mar 22, 2021 | Dec 2020 | $-0.89 | $-0.87 | - |
| Mar 20, 2020 | Dec 2019 | $0.00 | $-0.90 | - |
| Feb 19, 2019 | Dec 2018 | $-2.54 | $-1.94 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 28, 2022 | Dec 2021 | $0.00 | $0.00 | - |
| Nov 15, 2021 | Sep 2021 | $0.00 | $0.00 | - |
| Aug 12, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 17, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 22, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 13, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 13, 2020 | Jun 2020 | - | $0.00 | - |
| May 14, 2020 | Mar 2020 | - | $0.00 | - |
| Mar 20, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 14, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 13, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| May 13, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Feb 19, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Nov 14, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Jul 30, 2018 | Jun 2018 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 28, 2022 | Dec 2021 | $0.00 | $0.00 | - |
| Mar 22, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 20, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Feb 19, 2019 | Dec 2018 | $0.00 | $0.00 | - |
ADIL's next estimated earnings date (based on same quarter last year's report date) is May 17, 2022 for the fiscal quarter ending Mar 31, 2022.
Adial Pharmaceuticals's previous earnings date was Mar 28, 2022 for its fiscal quarter ended Dec 31, 2021.
ADIL's earnings per share (EPS) was $-0.28, missing the consensus analysts forecast of $-0.21 by -33.33%.
The EPS was lower than the previous fiscal quarter (Sep 2021) by 27.27%, and lower than the same period a year before (Dec 2020) by 12.00%.
Revenues were $0.00.
The company reported a net income of $-5.83M.Free cash flow for the quarter was $-2.37M , compared to $-3.53M last quarter and $-2.61M a year before.
Adial Pharmaceuticals's previous annual earnings date was Mar 28, 2022 for its fiscal year ended Dec 31, 2021.
ADIL's earnings per share (EPS) was $-1.05, missing the consensus analysts forecast of $-0.96 by 9.38% , and lower than the previous year's EPS (Dec 2020) by 20.69%.
Revenues were $0.00.
The company reported a net income of $-19.42M.
Adial Pharmaceuticals reported a free cash flow of $-12.01M for its fiscal year, compared to $-7.63M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
